|
Controls (n = 1057)
|
Gleason 6 PC (n = 402)
|
Gleason 7 PC (n = 272)
|
Gleason 8-10 PC (n = 135)
|
---|
|
Median
|
25th-75th
|
Median
|
25th-75th
|
Median
|
25th-75th
|
Median
|
25th-75th
|
p*
|
---|
Age (years)
|
64.0
|
58.0-70.0
|
64.5
|
59.0-70.0
|
66.0
|
61.0-72.0
|
69.0
|
64.0-75.0
|
< 0.01
|
PSA (ng/ml)
|
5.0
|
4.0-6.8
|
5.0
|
4.2-6.7
|
6.0
|
4.6-8.4
|
8.0
|
5.5-16.4
|
< 0.01
|
Prostate Volume (ml)
|
45.1
|
33.3-62.8
|
37.7
|
28.2-53.0
|
33.0
|
25.8-45.0
|
35.6
|
26.1-49.6
|
< 0.01
|
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
| |
Non-white ethnicity
|
103
|
9.7%
|
50
|
12.4%
|
38
|
13.9%
|
14
|
10.3%
|
0.17
|
Family History PC
|
215
|
20.3%
|
112
|
27.9%
|
58
|
21.3%
|
17
|
12.5%
|
< 0.01
|
Diabetes Tx
|
149
|
14.1%
|
50
|
12.4%
|
40
|
14.7%
|
22
|
16.3%
|
0.68
|
CVD Tx
|
591
|
55.9%
|
244
|
60.7%
|
171
|
62.9%
|
77
|
57.0%
|
0.12
|
BPH Tx
|
210
|
19.9%
|
74
|
18.4%
|
44
|
16.2%
|
16
|
11.9%
|
0.10
|
Hyperlipidemia Tx
|
436
|
41.3%
|
180
|
44.8%
|
121
|
55.5%
|
60
|
44.4%
|
0.54
|
-
P value from Chi-Square or Kruskal-Wallis test